VOICED : Regulador europeo aprueba dos tratamientos con anticuerpos para el covid-19

The European Medicines Agency (EMA) has approved two new COVID-19 treatments using monoclonal antibodies, Ronaprevé from Rocher and Regkirona from Celtrion. These are the first antibody-based drugs to receive positive evaluation from the EMA. Antibodies are crucial to our immune system, naturally produced to combat viruses. These therapies involve selecting and artificially producing antibodies for treatment, typically administered via injection. The EMA's approval comes as Europe faces a surge in COVID-19 cases.

What new insight or understanding did you gain from this video?